Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Biochemical and Biophysical Research Communications|March 21, 2003
Mouse mast cell protease-1 cleaves angiotensin I to form angiotensin IIKayo Saito, Tsuyoshi Muto, Yoshiaki Tomimori, et al.The Journal of Experimental Medicine|May 27, 2009
Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatumYuko Kawakami, Yoshiaki Tomimori, Kenji Yumoto, et al.European Journal of Pharmacology|October 25, 2003
Involvement of mast cell chymase in bleomycin-induced pulmonary fibrosis in miceYoshiaki Tomimori, Tsuyoshi Muto, Kayo Saito, et al.Bioorganic & Medicinal Chemistry Letters|April 10, 2007
Identification of 6-substituted 4-arylsulfonyl-1,4-diazepane-2,5-diones as a novel scaffold for human chymase inhibitorsTaisaku Tanaka, Tsuyoshi Muto, Hiroshi Maruoka, et al.Antiviral Therapy|February 12, 2011
Protective murine and human monoclonal antibodies against eczema vaccinatumYoshiaki Tomimori, Yuko Kawakami, Megan M McCausland, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2009
A minor catalytic activity of Src family kinases is sufficient for maximal activation of mast cells via the high-affinity IgE receptorMichael Poderycki, Yoshiaki Tomimori, Tomoaki Ando, et al.International Immunopharmacology|June 7, 2011
Pharmacokinetic/pharmacodynamic analyses of chymase inhibitor SUN13834 in NC/Nga mice and prediction of effective dosage for atopic dermatitis patientsAtsuto Ogata, Yusuke Fujieda, Maki Terakawa, et al.European Journal of Pharmacology|November 11, 2008
Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitisMaki Terakawa, Yusuke Fujieda, Yoshiaki Tomimori, et al.Biochemical Pharmacology|September 18, 2002
Role of mast cell chymase in allergen-induced biphasic skin reactionYoshiaki Tomimori, Nobuo Tsuruoka, Harukazu Fukami, et al.European Journal of Pharmacology|October 16, 2025
Enhancement of chloride transport via Ca2+ mobilization in airway epithelial cells by DS-1039, a novel selective GPR39 agonistSatoshi Muneoka, Norio Inomata, Kei Enomoto, et al.Pageof 3